Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Acta Obstetricia Et Gynecologica Scandinavica
|
December 22, 2025
Biopsy-proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome-Retrospective single-center cohort study
Christoph Ebner, Ricarda Purtscheller, Barin Feroz, et al.
Radiation Oncology (London, England)
|
April 1, 2026
Intensity-modulated radiotherapy/Volumetric modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer
Barin Feroz, Christoph Ebner, Sergej Skvortsov, et al.
Blood
|
November 19, 2005
Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia
Stefan Schmidt, Johannes Rainer, Stefan Riml, et al.
Cancer Research
|
June 19, 2007
MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps
Shailaja Kasibhatla, Vijay Baichwal, Sui Xiong Cai, et al.
JCI Insight
|
July 8, 2021
Ferritin H deficiency deteriorates cellular iron handling and worsens Salmonella typhimurium infection by triggering hyperinflammation
David Haschka, Piotr Tymoszuk, Verena Petzer, et al.
Radiology and Oncology
|
February 16, 2020
Molecular heterogeneity in breast carcinoma cells with increased invasive capacities
Giulia Negro, Bertram Aschenbrenner, Simona Kranjc Brezar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 11, 2010
Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse
Ira Skvortsova, Sergej Skvortsov, Uma Raju, et al.
Molecular Cancer Therapeutics
|
July 2, 2009
Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib
Judith Loeffler-Ragg, Doris Mueller, Gabriele Gamerith, et al.
Theranostics
|
August 2, 2021
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
Anna Mukha, Uğur Kahya, Annett Linge, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Acta Obstetricia Et Gynecologica Scandinavica
|
December 22, 2025
Biopsy-proven residual cervical cancer at the end of combined chemoradiation predicts poor outcome-Retrospective single-center cohort study
Christoph Ebner, Ricarda Purtscheller, Barin Feroz, et al.
Radiation Oncology (London, England)
|
April 1, 2026
Intensity-modulated radiotherapy/Volumetric modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer
Barin Feroz, Christoph Ebner, Sergej Skvortsov, et al.
Blood
|
November 19, 2005
Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia
Stefan Schmidt, Johannes Rainer, Stefan Riml, et al.
Cancer Research
|
June 19, 2007
MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps
Shailaja Kasibhatla, Vijay Baichwal, Sui Xiong Cai, et al.
JCI Insight
|
July 8, 2021
Ferritin H deficiency deteriorates cellular iron handling and worsens Salmonella typhimurium infection by triggering hyperinflammation
David Haschka, Piotr Tymoszuk, Verena Petzer, et al.
Radiology and Oncology
|
February 16, 2020
Molecular heterogeneity in breast carcinoma cells with increased invasive capacities
Giulia Negro, Bertram Aschenbrenner, Simona Kranjc Brezar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 11, 2010
Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse
Ira Skvortsova, Sergej Skvortsov, Uma Raju, et al.
Molecular Cancer Therapeutics
|
July 2, 2009
Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib
Judith Loeffler-Ragg, Doris Mueller, Gabriele Gamerith, et al.
Theranostics
|
August 2, 2021
GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
Anna Mukha, Uğur Kahya, Annett Linge, et al.
Page
of 4